International Conference on Peer Review

International Conference on Peer Review
Name	International Conference on Peer Review
Status	Active
Genre	Scholarly conference
Frequency	Biennial
Location	Rotating international venues
First	1989
Organizer	Association of Medical Journal Editors

International Conference on Peer Review The International Conference on Peer Review is a recurring scholarly meeting that examines practices in editorial processes, scientific publishing, and research integrity. Founded in the late 20th century, the Conference convenes researchers, editors, policymakers, and funders to evaluate evidence about peer review, reproducibility, and publication ethics. Attendees commonly include representatives from major journals, academic institutions, governmental agencies, and philanthropic foundations.

History

The Conference originated from discussions among editors of leading journals such as The Lancet, The New England Journal of Medicine, Nature (journal), Science (journal), and JAMA in the 1980s, with inaugural meetings influenced by debates at venues like Harvard University, Johns Hopkins University, Oxford University, Cambridge University, and Stanford University. Early iterations engaged stakeholders including the World Health Organization, National Institutes of Health, Medical Research Council (United Kingdom), Wellcome Trust, and publishers such as Elsevier, Wiley-Blackwell, Springer Nature, and Taylor & Francis. Over time the Conference attracted policy actors from European Commission, United States Congress, National Science Foundation, and advocacy groups like COPE and PLOS. Milestones included methodological sessions drawing on research from RAND Corporation, Cochrane Collaboration, Institute of Medicine (US), and think tanks such as Brookings Institution.

Objectives and Theme Topics

The Conference sets objectives to improve transparency, reduce bias, and enhance reproducibility across disciplines represented by institutions like American Medical Association, American Association for the Advancement of Science, Royal Society, Academy of Medical Sciences (UK), and Chinese Academy of Sciences. Typical themes intersect with initiatives by Open Science Framework, ORCID, CrossRef, Retraction Watch, and PubMed Central. Session topics often reference frameworks from Declaration of Helsinki, Singapore Statement on Research Integrity, DORA, and regulatory considerations from agencies like Food and Drug Administration, European Medicines Agency, and Health Research Authority (UK).

Organization and Governance

Governance is typically managed by advisory boards composed of editors and representatives from organizations such as Committee on Publication Ethics, International Committee of Medical Journal Editors, World Association of Medical Editors, and funders including Wellcome Trust, Gates Foundation, and National Institutes of Health. Local organizing committees have included academic departments at University of Oxford, University College London, Yale University, University of Toronto, and Karolinska Institutet. Corporate partners have ranged from legacy publishers like Macmillan Publishers to open-access platforms such as eLife and F1000Research. Registration, sponsorship, and policy statements have sometimes involved legal counsel from firms experienced with intellectual property matters invoked in cases like Elsevier v. Sci-Hub.

Notable Conferences and Milestones

Notable editions addressed crises and reforms linked to events such as the Wakefield (Andrew) controversy and controversies exposed by investigations in The New Yorker and The Lancet mass retractions. Milestones include implementation discussions of open peer review models adopted by journals such as BMJ, eLife, PeerJ, and platforms like PubPeer. Sessions have highlighted reproducibility initiatives led by Center for Open Science, large-scale studies from Reproducibility Project: Psychology, and data-sharing policies promoted by Dryad and Figshare.

Keynote Speakers and Participants

Keynote speakers have included prominent figures affiliated with institutions like Harvard Medical School, Massachusetts Institute of Technology, Princeton University, University of Cambridge, and University of Oxford, alongside leaders from National Institutes of Health, European Commission, and foundations such as Wellcome Trust and Bill & Melinda Gates Foundation. Participants often include editors from Nature (journal), Science (journal), Cell (journal), Proceedings of the National Academy of Sciences, and policy scholars from Stanford Center for Biomedical Ethics, Yale School of Medicine, and Columbia University.

Impact on Peer Review Practices and Policy

The Conference has influenced adoption of practices promoted by Open Access (publishing), preprint servers like arXiv, bioRxiv, and medRxiv, and identifiers such as ORCID. It has informed editorial guidelines used by International Committee of Medical Journal Editors, influenced patent-related disclosure norms considered by European Patent Office, and shaped funder mandates from Wellcome Trust and National Institutes of Health. Evidence presented at sessions has fed into policy reports by Organisation for Economic Co-operation and Development, World Health Organization, and national science agencies like National Science Foundation and UK Research and Innovation.

Criticisms and Controversies

Critics have challenged the Conference on grounds echoed in debates involving Retraction Watch, Science (journal), Nature (journal), and investigations by The New York Times and The Guardian regarding conflicts of interest, publisher influence, and slow adoption of reforms. Controversies have paralleled litigations and disputes surrounding Sci-Hub, debates over metrics referenced in DORA, and tensions between traditional publishers such as Elsevier and open-access advocates like Public Library of Science. Some commentators from institutions including University of California systems and Max Planck Society have called for stronger independence and transparency in governance.

Category:Academic conferences